Pages that link to "Q28069384"

The following pages link to Plasmodium falciparum: multifaceted resistance to artemisinins (Q28069384):

Displaying 27 items.

• Artemisinin Action and Resistance in Plasmodium falciparum (Q28276294) (← links)
• Plasmodium falciparum GFP-E-NTPDase expression at the intraerythrocytic stages and its inhibition blocks the development of the human malaria parasite (Q30041136) (← links)
• Absence of in vivo selection for K13 mutations after artemether-lumefantrine treatment in Uganda (Q37576425) (← links)
• In vitro activity of anti-malarial ozonides against an artemisinin-resistant isolate (Q37607795) (← links)
• Polymeric therapeutic delivery systems for the treatment of infectious diseases (Q39386505) (← links)
• Protein Degradation Systems as Antimalarial Therapeutic Targets (Q39422863) (← links)
• Functional analysis of Plasmodium falciparum subpopulations associated with artemisinin resistance in Cambodia. (Q47100748) (← links)
• Endoperoxide-based compounds: cross-resistance with artemisinins and selection of a Plasmodium falciparum lineage with a K13 non-synonymous polymorphism. (Q47362967) (← links)
• Activities of 11-Azaartemisinin and N-Sulfonyl Derivatives against Asexual and Transmissible Malaria Parasites. (Q48018805) (← links)
• Drug resistance in Plasmodium. (Q48022767) (← links)
• Remodeling of the malaria parasite and host human red cell by vesicle amplification that induces artemisinin resistance (Q48023117) (← links)
• Plasmodium falciparum resistance to artemisinin-based combination therapies: A sword of Damocles in the path toward malaria elimination. (Q52575118) (← links)
• Altered life history strategies protect malaria parasites against drugs. (Q53696597) (← links)
• Artemisinin-Resistant Plasmodium falciparum with High Survival Rates, Uganda, 2014-2016. (Q53701065) (← links)
• Repurposing drugs to target the malaria parasite unfolding protein response. (Q55560161) (← links)
• Artemisone and Artemiside Are Potent Panreactive Antimalarial Agents That Also Synergize Redox Imbalance in Plasmodium falciparum Transmissible Gametocyte Stages (Q56355670) (← links)
• Population Pharmacokinetics of the Antimalarial Amodiaquine: a Pooled Analysis To Optimize Dosing (Q56358106) (← links)
• Facile Preparation of -Glycosylated 10-Piperazinyl Artemisinin Derivatives and Evaluation of Their Antimalarial and Cytotoxic Activities (Q56363425) (← links)
• In search of the representative pharmacophore hypotheses of the enzymatic proteome of Plasmodium falciparum: a multicomplex-based approach (Q57471866) (← links)
• Oral Ingestion of Cannabis sativa: Risks, Benefits, and Effects on Malaria-Infected Hosts (Q59332848) (← links)
• Plasmodium chaperonin TRiC/CCT identified as a target of the antihistamine clemastine using parallel chemoproteomic strategy (Q90008883) (← links)
• A biosynthetic platform for antimalarial drug discovery (Q90167617) (← links)
• Epidemiology of Plasmodium falciparum infection and drug resistance markers in Ota Area, Southwestern Nigeria (Q91906180) (← links)
• Comparative structural and evolutionary analyses predict functional sites in the artemisinin resistance malaria protein K13 (Q92134518) (← links)
• Protozoan persister-like cells and drug treatment failure (Q92833523) (← links)
• Optimal 10-Aminoartemisinins With Potent Transmission-Blocking Capabilities for New Artemisinin Combination Therapies-Activities Against Blood Stage P. falciparum Including PfKI3 C580Y Mutants and Liver Stage P. berghei Parasites (Q93054765) (← links)
• Phosphatidylinositol 3-phosphate and Hsp70 protect Plasmodium falciparum from heat-induced cell death (Q99716323) (← links)